Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 255 | 238 | 121 | 70 | 162 |
| Gross Profit | 255 | 238 | 121 | 70 | 162 |
| Operating Expenses | 1,050 | 685 | 726 | 784 | 962 |
| Operating Income | -795 | -447 | -605 | -714 | -800 |
| Interest Expense | 61 | 57 | 59 | 62 | 51 |
| Other Income | 9 | 0 | 0 | 0 | 16 |
| Pre-tax Income | -847 | -504 | -663 | -776 | -835 |
| Net Income Continuous | -847 | -504 | -663 | -776 | -835 |
| Net Income | $-847 | $-504 | $-663 | $-776 | $-835 |
| EBITDA(a) | $-793 | $-445 | $-603 | $-712 | $-798 |